Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Short-term Investments (2018 - 2025)

Historic Short-term Investments for Dna X (SONM) over the last 7 years, with Q3 2025 value amounting to $2.2 million.

  • Dna X's Short-term Investments changed N/A to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2024, which is 126903.55% up from last year.
  • Per Dna X's latest filing, its Short-term Investments stood at $2.2 million for Q3 2025.
  • Over the past 5 years, Dna X's Short-term Investments peaked at $3.4 million during Q2 2025, and registered a low of $197000.0 during Q4 2023.
  • Over the past 4 years, Dna X's median Short-term Investments value was $2.4 million (recorded in 2024), while the average stood at $2.1 million.
  • In the last 5 years, Dna X's Short-term Investments tumbled by 812.0% in 2021 and then surged by 126903.55% in 2024.
  • Quarter analysis of 4 years shows Dna X's Short-term Investments stood at $1.0 million in 2021, then plummeted by 81.08% to $197000.0 in 2023, then soared by 1269.04% to $2.7 million in 2024, then decreased by 18.95% to $2.2 million in 2025.
  • Its Short-term Investments stands at $2.2 million for Q3 2025, versus $3.4 million for Q2 2025 and $2.8 million for Q1 2025.